News

The Manila Times7d

Silexion Therapeutics Announces Exercise of Warrants for $1.8 Million Gross Proceeds

Silexion Therapeutics Corp. (NASDAQ: SLXN) ('Silexion Therapeutics” or the 'Company”), a clinical-stage biotech company ...